source
- Tirabrutinib and CAR T-cell therapy show promise for relapsed/refractory primary CNS lymphomaExperts highlighted emerging data on tirabrutinib and CAR T-cell therapy as potential new options for patients with relapsed or refractory primary central nervous system lymphoma. CAR T-cell thera…
- Trump administration seeks new FDA commissioner to restore trust, prioritize food policy and accelerate drug approvalsThe Trump administration is moving quickly to name a successor to FDA commissioner Marty Makary, who resigned. Officials say the search will take several weeks and they are looking for a leader wh…